dr. aoife corrigan - issues in developing alternatives to antimicrobials

31
Competing with antibiotic growth promoters the issues... Aoife Corrigan, Ph.D. Alltech Bioscience Centre Ireland November 2012

Upload: john-blue

Post on 18-Jul-2015

245 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Competing with antibiotic growth promoters – the issues...

Aoife Corrigan, Ph.D.Alltech Bioscience Centre

Ireland

November 2012

Page 2: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Are we ready for

9 billion ???

The World needs to

double the meat

production in the next

50 years

Page 3: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

What are the challenges?• Changes in the world economy

• Impact of the transportation of foods

• Food security: Food chain safety and traceability

• Food sufficiency: Efficiency of food production

• Effective nutrient utilization

• EU ban on AGPs

Page 4: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Who has the responsibility?

• a farm-to-fork approach.

• the responsibility for the production of safe

food lies with the primary animal producer

up through the food chain to the consumer

Page 5: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

In the past we used

antibiotics to mask the

underlying problems

related to optimum gut

health and function…..

and food safety!

Page 6: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Why do we worry?

Antibiotic Resistance

Food safety

Gut health

Page 7: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Antibiotics

AGPs have a long history of prophylactic use in animal feed to improve animal performance and health status by targeting and destroying the intestinal microflora.

interfering with the bacteria's ability to reproduce

damaging cell membranes

disrupting essential cellular activities

Most AGPs target gram-positive organisms that are commonly associated with poor health and reduced animal performance

Economic benefit of feeding prophylactic AGPs improvement of growth, health and uniformity

The size of response to AGPs is dependent on:

farm management, exposure to pathogens, environmental stresses and diet.

Page 8: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Alternatives to AGPs must meet

the same expectations and also

meet regulatory requirements

Safe

Cost effective

Non toxic

Cannot become resistant???

Efficacious

Page 9: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Where do we start?

• Education and information

• Slaughter house hygienic measures

• Breeders

• Pathogen free feed

• Biosecurity– Internal and External

• Holistic approach

• Focus on gut health and immunity– More research needed

Page 10: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

What’s happening?

Animation by Alltech

What are our options with out AGP’s

Page 11: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Healthy gut

Optimal gut

health

Balanced

intestinal

microflora

Optimal animal

performance

Nutrition and

management

Gut wall morphology,

integrity and

inflammation

Page 12: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

What feed intervention

strategies are available?

• Heat treatment

• Organic acids

• Physicalcharacteristics

• Probiotics

– CompetitiveExclusion

• Glycans

• Medium chain fattyacids

• Essential oils

• Prebiotics

Page 13: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Alternatives, How do they work?

Altering gut pH

Maintaining protective gut Mucin

Selection for beneficial intestinal organisms or

against pathogens

Enhancing fermentation acids,

Enhancing nutrient uptake

Increasing the humoral immune response.

Page 14: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Mannan-oligosaccharides

• Salmonella contain mannose-specific lectins (Type 1 fimbriae) on the bacterial surface that binds to glycoproteins (rich in mannose) on the intestinal surface.

• Mannose sugars can thereby compete with the intestinal glycoproteins for attachment sites and prevent colonization.

• Salmonella binding has been demonstrated with mannan- oligosaccharide (Bio-Mos) at significantly lower concentrations than that required for purified mannose. (Spring 2000)

Page 15: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Does it address the specific issues

when looking for an AGP

alternative? Safe -

Cost effective -

Non toxic -

Unlikely to become resistant -

Efficacious - Does it achieve the same aims of

an AGP?

Page 16: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Disease control

Reduction Salmonellainfection rate

80

10

0

10

20

30

40

50

60

70

80

90

Control Bio-Mos

% S

alm

on

ella

po

siti

ve s

amp

les

MOS reduced the average mortality

by 27%

Bio-Mos used 62 g less feed to

produce 1 kg of body weight,

corresponding to an improvement

of 3.24%

With MOS, the infection rate

decreased to 1/8 of the previous

rate in the previous cycles

6.6

4.8

0.0

1.0

2.0

3.0

4.0

5.0

6.0

7.0

Control Bio-Mos

%

Improvement in mortality

1.92

1.85

1.82

1.83

1.84

1.85

1.86

1.87

1.88

1.89

1.90

1.91

1.92

Control Bio-Mos

Improvement in FCR

Page 17: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Works as an alternative in terms of

performance

But also has added effects on

Intestinal structure

Mucin production

Digestion

Immune modulation

Page 18: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Goblet cells and Mucin

Mucin is a mucous gel secreted by epithelial

goblet cells that acts as a protective barrier against

harmful intraluminal components such as:

Abrasive action of feedstuffs

Bacteria colonization

Toxins

Page 19: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

How do MOS affect intestinal structure ?

• Reduction in pathogenic bacteria

• Leads to a reduction in cell sloughing on the villi

• Less energy expended maintaining GI tract

• Mannan may aid in tissue repair

Page 20: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Focusing on specific

genomic effects:

Individual gene markers

Page 21: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Ave

rag

e s

ign

al in

ten

sit

y

Wheat Corn Bio-Mos Actigen

MUC2 P = 0.08MUC5B

Ave

rag

e s

ign

al in

ten

sit

y

Wheat Corn Bio-Mos Actigen

Regulation of mucin associated genes

in intestinal tissue of broilers by MOS

Page 22: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials
Page 23: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials
Page 24: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

MOS also has an effect on immunity

• Innate immunity

– attenuated mucus secretion

• Acute Phase response

– suppression of the fever response

• Humoral immunity

– enhanced antigen presentation to immune cells

– modulated antibody production

Page 25: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

LYZ

Effects of MOS on genes

related to immune

related genes

Ave

rag

e s

ign

al in

ten

sit

y

Wheat Corn Bio-Mos Actigen

*

*

*

Ave

rag

e s

ign

al in

ten

sit

y

Wheat Corn Bio-Mos Actigen

B2M

**

Page 26: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials
Page 27: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials
Page 28: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

0

1

2

3

4

5

6

7

8

9

Control Day 28

Bio-Mos Day28

Control Day 35

Bio-Mos Day 35

Control Day 42

Bio-Mos Day 42

Lo

g G

en

e C

op

y N

um

ber

0

1

2

3

4

5

6

7

8

9

Control Day 28

Bio-Mos Day28

Control Day 35

Bio-Mos Day 35

Control Day 42

Bio-Mos Day 42

Lo

g G

en

e C

op

y N

um

ber

Reduction in the levels of AB resistance genes being carried in the intestine

• Significant reduction in levels of tet A gene (p ≤ 0.05)and tet B gene (p ≤ 0.037) seen following 42 days supplementation with MOS

* **

Page 29: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Conclusions

• There will always be a need for

antibiotic use

• Need to try and minimise and

conserve their use

• No silver bullet approach

• Combined approach

©

Page 30: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Three key strategies for

limiting the use of

Antibiotics on farm• Infection control

– Operate an all-in all-out policy

– Minimise mixing of animals

• Good hygiene– Good hygiene practices, especially production

phases

– Ensure all pens & feeders are disinfected

between batches

• Nutritional support– Mos inclusion to reduce colonization and

alleviate disease pressure

©

Page 31: Dr. Aoife Corrigan - Issues in Developing Alternatives to Antimicrobials

Can we switch to AGP

alternatives - yes

Safe -

Cost effective -

Non toxic -

Unlikely to become resistant - ????

Efficacious -